Published in Pharm Res on November 11, 2008
Fusion protein linkers: property, design and functionality. Adv Drug Deliv Rev (2012) 1.67
Human growth hormone-transferrin fusion protein for oral delivery in hypophysectomized rats. J Control Release (2009) 1.10
Advances and challenges in analytical characterization of biotechnology products: mass spectrometry-based approaches to study properties and behavior of protein therapeutics. Biotechnol Adv (2011) 1.07
Harnessing the unique structural properties of isolated α-helices. J Biol Chem (2014) 0.94
An improved smaller biotin ligase for BioID proximity labeling. Mol Biol Cell (2016) 0.90
Effects of receptor binding on plasma half-life of bifunctional transferrin fusion proteins. Mol Pharm (2011) 0.89
Transferrin as a model system for method development to study structure, dynamics and interactions of metalloproteins using mass spectrometry. Biochim Biophys Acta (2011) 0.89
Design of an in vivo cleavable disulfide linker in recombinant fusion proteins. Biotechniques (2010) 0.83
Synthetic Protein Scaffolds Based on Peptide Motifs and Cognate Adaptor Domains for Improving Metabolic Productivity. Front Bioeng Biotechnol (2015) 0.77
In Silico Design of a Chimeric Protein Containing Antigenic Fragments of Helicobacter pylori; A Bioinformatic Approach. Open Microbiol J (2016) 0.76
Overexpression of Fas and FasL is associated with infectious complications and severity of experimental severe acute pancreatitis by promoting apoptosis of lymphocytes. Inflammation (2014) 0.76
Development and characterization of a novel fusion protein of a mutated granulocyte colony-stimulating factor and human serum albumin in Pichia pastoris. PLoS One (2014) 0.75
Detection of a phosphorylated glycine-serine linker in an IgG-based fusion protein. MAbs (2016) 0.75
The CD4 and CD3δε Cytosolic Juxtamembrane Regions Are Proximal within a Compact TCR-CD3-pMHC-CD4 Macrocomplex. J Immunol (2016) 0.75
Helix stabilization by Glu-...Lys+ salt bridges in short peptides of de novo design. Proc Natl Acad Sci U S A (1987) 5.73
Production of recombinant protein therapeutics in cultivated mammalian cells. Nat Biotechnol (2004) 5.67
Protein therapeutics: a summary and pharmacological classification. Nat Rev Drug Discov (2008) 4.32
Simultaneous targeting of multiple disease mediators by a dual-variable-domain immunoglobulin. Nat Biotechnol (2007) 2.53
Design of the linkers which effectively separate domains of a bifunctional fusion protein. Protein Eng (2001) 2.40
High-level expression of soluble protein in Escherichia coli using a His6-tag and maltose-binding-protein double-affinity fusion system. Protein Expr Purif (1997) 2.15
Optimizing the stability of single-chain proteins by linker length and composition mutagenesis. Proc Natl Acad Sci U S A (1998) 1.87
Recombinant protein production by large-scale transient gene expression in mammalian cells: state of the art and future perspectives. Biotechnol Lett (2007) 1.52
Large-scale transient expression in mammalian cells for recombinant protein production. Curr Opin Biotechnol (1999) 1.38
Albinterferon alpha-2b: a genetic fusion protein for the treatment of chronic hepatitis C. Nat Biotechnol (2007) 1.27
Recombinant granulocyte colony-stimulating factor-transferrin fusion protein as an oral myelopoietic agent. Proc Natl Acad Sci U S A (2005) 1.25
Transient gene expression in HEK293 cells: peptone addition posttransfection improves recombinant protein synthesis. Biotechnol Bioeng (2005) 1.17
Conformations of variably linked chimeric proteins evaluated by synchrotron X-ray small-angle scattering. Proteins (2004) 1.14
Improving the oral efficacy of recombinant granulocyte colony-stimulating factor and transferrin fusion protein by spacer optimization. Pharm Res (2006) 1.07
Strategy for selecting and characterizing linker peptides for CBM9-tagged fusion proteins expressed in Escherichia coli. Biotechnol Bioeng (2007) 0.92
A novel specific bioassay for serum human growth hormone. J Clin Endocrinol Metab (2000) 0.90
Engineering of functional chimeric protein G-Vargula luciferase. Anal Biochem (1997) 0.89
Production and characterization of fusion proteins containing transferrin and nerve growth factor. J Drug Target (1998) 0.84
Sodium butyrate alters erythropoietin glycosylation via multiple mechanisms. Biotechnol Bioeng (2008) 0.83
Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08
Cell penetrating peptides: intracellular pathways and pharmaceutical perspectives. Pharm Res (2007) 2.08
Fusion protein linkers: property, design and functionality. Adv Drug Deliv Rev (2012) 1.67
Proinsulin-transferrin fusion protein as a novel long-acting insulin analog for the inhibition of hepatic glucose production. Diabetes (2013) 1.44
Recombinant granulocyte colony-stimulating factor-transferrin fusion protein as an oral myelopoietic agent. Proc Natl Acad Sci U S A (2005) 1.25
Human growth hormone-transferrin fusion protein for oral delivery in hypophysectomized rats. J Control Release (2009) 1.10
Transcytosis of GCSF-transferrin across rat alveolar epithelial cell monolayers. Pharm Res (2003) 1.09
Arsenite-oxidizing and arsenate-reducing bacteria associated with arsenic-rich groundwater in Taiwan. J Contam Hydrol (2010) 1.09
Improving the oral efficacy of recombinant granulocyte colony-stimulating factor and transferrin fusion protein by spacer optimization. Pharm Res (2006) 1.07
Resistance to the anti-proliferative activity of recombinant arginine deiminase in cell culture correlates with the endogenous enzyme, argininosuccinate synthetase. Cancer Lett (2003) 1.04
Oral peptide and protein delivery: unfulfilled promises? Drug Discov Today (2003) 1.04
Modulation of arginine metabolic pathways as the potential anti-tumor mechanism of recombinant arginine deiminase. Cancer Lett (2006) 1.02
Recombinant arginine deiminase as a differential modulator of inducible (iNOS) and endothelial (eNOS) nitric oxide synthetase activity in cultured endothelial cells. Biochem Pharmacol (2003) 0.99
Reversible lipidization for the oral delivery of salmon calcitonin. J Control Release (2003) 0.97
Drug evaluation: ADI-PEG-20--a PEGylated arginine deiminase for arginine-auxotrophic cancers. Curr Opin Mol Ther (2006) 0.96
Blue light negatively regulates the sexual filamentation via the Cwc1 and Cwc2 proteins in Cryptococcus neoformans. Mol Microbiol (2005) 0.95
Reversible lipidization for the oral delivery of leu-enkephalin. J Drug Target (2006) 0.93
Accessibility of endothelial and inducible nitric oxide synthase to the intracellular citrulline-arginine regeneration pathway. Biochem Pharmacol (2005) 0.92
Quantitative comparison of membrane transduction and endocytosis of oligopeptides. Biochem Biophys Res Commun (2003) 0.92
The transepithelial transport of a G-CSF-transferrin conjugate in Caco-2 cells and its myelopoietic effect in BDF1 mice. Pharm Res (2004) 0.92
Comparison of cationic and amphipathic cell penetrating peptides for siRNA delivery and efficacy. Mol Pharm (2011) 0.91
Effects of receptor binding on plasma half-life of bifunctional transferrin fusion proteins. Mol Pharm (2011) 0.89
Transferrin-oligomers as potential carriers in anticancer drug delivery. Pharm Res (2004) 0.89
Membrane transduction of oligoarginine in HeLa cells is not mediated by macropinocytosis. Mol Pharm (2006) 0.88
Effects of Lipofectamine 2000/siRNA complexes on autophagy in hepatoma cells. Mol Biotechnol (2012) 0.87
A homolog of Ste6, the a-factor transporter in Saccharomyces cerevisiae, is required for mating but not for monokaryotic fruiting in Cryptococcus neoformans. Eukaryot Cell (2005) 0.86
Comparison of monomeric and oligomeric transferrin as potential carrier in oral delivery of protein drugs. J Control Release (2005) 0.86
Reversible lipidization prolongs the pharmacological effect, plasma duration, and liver retention of octreotide. Pharm Res (2005) 0.86
Nuclear localization of cell-penetrating peptides is dependent on endocytosis rather than cytosolic delivery in CHO cells. Mol Pharm (2009) 0.85
Receptor-mediated activation of a proinsulin-transferrin fusion protein in hepatoma cells. J Control Release (2011) 0.84
Recombinant peptide constructs for targeted cell penetrating peptide-mediated delivery. J Control Release (2012) 0.84
Evidence that membrane transduction of oligoarginine does not require vesicle formation. Exp Cell Res (2005) 0.84
Design of an in vivo cleavable disulfide linker in recombinant fusion proteins. Biotechniques (2010) 0.83
Disulfide and thioether linked cytochrome c-oligoarginine conjugates in HeLa cells. Int J Pharm (2008) 0.83
The influence of net charge and charge distribution on cellular uptake and cytosolic localization of arginine-rich peptides. J Drug Target (2010) 0.83
Characterization of transferrin receptor-mediated endocytosis and cellular iron delivery of recombinant human serum transferrin from rice (Oryza sativa L.). BMC Biotechnol (2012) 0.82
Fatty acids as therapeutic auxiliaries for oral and parenteral formulations. Adv Drug Deliv Rev (2012) 0.81
Enhancement of insulin transport across primary rat alveolar epithelial cell monolayers by endogenous cellular factor(s). Pharm Res (2007) 0.80
Mass spectrometry study of a transferrin-based protein drug reveals the key role of protein aggregation for successful oral delivery. Proc Natl Acad Sci U S A (2012) 0.80
Cryptococcus neoformans mediator protein Ssn8 negatively regulates diverse physiological processes and is required for virulence. PLoS One (2011) 0.80
Cytosolic delivery of a p16-peptide oligoarginine conjugate for inhibiting proliferation of MCF7 cells. J Control Release (2005) 0.79
Accumulation of transferrin in Caco-2 cells: a possible mechanism of intestinal transferrin absorption. J Control Release (2007) 0.79
A screening for suppressor mutants reveals components involved in the blue light-inhibited sexual filamentation in Cryptococcus neoformans. Fungal Genet Biol (2008) 0.79
SV40 T/t-common polypeptide specifically induces apoptosis in human cancer cells that overexpress HER2/neu. Cancer Res (2006) 0.79
Tyrphostin A8 stimulates a novel trafficking pathway of apically endocytosed transferrin through Rab11-enriched compartments in Caco-2 cells. Am J Physiol Cell Physiol (2007) 0.79
MAP-mediated nuclear delivery of a cargo protein. J Drug Target (2012) 0.79
Lipidization of human interferon-alpha: a new approach toward improving the delivery of protein drugs. J Control Release (2008) 0.78
Fast preparation of fungal DNA for PCR screening. J Microbiol Methods (2011) 0.78
Effects of spermine-conjugated Bowman-Birk inhibitor (spermine-BBI) on carcinogenesis and cholesterol biosynthesis in mice. Pharm Res (2003) 0.78
Conjugation with cationic cell-penetrating peptide increases pulmonary absorption of insulin. Mol Pharm (2009) 0.78
Pharmacokinetics of recombinant bifunctional fusion proteins. Expert Opin Drug Metab Toxicol (2012) 0.77
Vesicle-to-cytosol transport of disulfide-linked cargo mediated by an amphipathic cell-penetrating peptide. J Drug Target (2012) 0.77
Mating differentiation in Cryptococcus neoformans is negatively regulated by the Crk1 protein kinase. Fungal Genet Biol (2010) 0.77
Structure-activity relationship of reversibly lipidized peptides: studies of fatty acid-desmopressin conjugates. Pharm Res (2002) 0.77
Characterization of protein factor(s) in rat bronchoalveolar lavage fluid that enhance insulin transport via transcytosis across primary rat alveolar epithelial cell monolayers. Eur J Pharm Biopharm (2008) 0.76
Phylogenetic study of two truffles, Tuber formosanum and Tuber furfuraceum, identified from Taiwan. FEMS Microbiol Lett (2009) 0.76
Reversible lipidization of somatostatin analogues for the liver targeting. Eur J Pharm Biopharm (2008) 0.76
Interaction between cell-penetrating peptides and acid-sensitive anionic oligopeptides as a model for the design of targeted drug carriers. Mol Pharm (2014) 0.75
Molecular and functional expression of multidrug resistance-associated protein-1 in primary cultured rat alveolar epithelial cells. J Pharm Sci (2008) 0.75